Samuel Zachary Goldhaber

Samuel Zachary Goldhaber's AcademicInfluence.com Rankings

Philosophy

#2444

World Rank

#4178

Historical Rank

Logic

#590

World Rank

#1057

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Samuel Zachary Goldhaber's Degrees

Doctorate Medicine Harvard University

Why Is Samuel Zachary Goldhaber Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Samuel Zachary Goldhaber's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) (5208)
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) (1999) (2782)
Dabigatran versus warfarin in the treatment of acute venous thromboembolism. (2009) (2402)
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020) (1949)
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association (2011) (1771)
An overview of randomized trials of rehabilitation with exercise after myocardial infarction. (1989) (1413)
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study (2008) (1372)
Fibrinolysis for patients with intermediate-risk pulmonary embolism. (2014) (1108)
Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. (1993) (1048)
Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients (2004) (933)
ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION (1992) (920)
Electronic alerts to prevent venous thromboembolism among hospitalized patients. (2005) (895)
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis (2014) (855)
Pulmonary embolism and deep vein thrombosis (2012) (803)
Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion (1993) (800)
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. (2013) (799)
Low‐Dose Methotrexate for the Prevention of Atherosclerotic Events (2019) (733)
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. (2003) (681)
A pharmacogenetic versus a clinical algorithm for warfarin dosing. (2013) (667)
Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. (1996) (655)
A prospective study of risk factors for pulmonary embolism in women. (1997) (604)
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. (2015) (599)
Ventricular dysfunction and the risk of stroke after myocardial infarction. (1997) (579)
Prospective study of exogenous hormones and risk of pulmonary embolism in women (1996) (575)
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. (1985) (564)
Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. (1992) (551)
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. (2011) (528)
Right Ventricular Enlargement on Chest Computed Tomography: A Predictor of Early Death in Acute Pulmonary Embolism (2004) (519)
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. (2007) (498)
Echocardiography in the Management of Pulmonary Embolism (2002) (493)
A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. (2004) (486)
Massive Pulmonary Embolism (2006) (465)
Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. (2003) (455)
Pharmacomechanical Catheter‐Directed Thrombolysis for Deep‐Vein Thrombosis (2017) (448)
Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). (2011) (446)
Upper-extremity deep vein thrombosis. (2002) (432)
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry (2013) (431)
Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. (2005) (430)
Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension (2001) (422)
Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy (2003) (404)
Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary Embolism (2003) (397)
Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. (2005) (385)
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients. (2016) (379)
Right Ventricular Enlargement on Chest Computed Tomography: Prognostic Role in Acute Pulmonary Embolism (2004) (372)
Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study (2007) (350)
Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis. (2003) (349)
Prevention and treatment of venous thromboembolism - International Consensus Statement (Guidelines according to scientific evidence) (2006) (344)
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. (2005) (332)
Upper-Extremity Deep Vein Thrombosis: A Prospective Registry of 592 Patients (2004) (324)
RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISM (1988) (318)
Acute Pulmonary Embolectomy: A Contemporary Approach (2002) (306)
Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. (1995) (303)
Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. (2003) (301)
Factors associated with correct antemortem diagnosis of major pulmonary embolism. (1982) (296)
Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. (1997) (283)
Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. (1995) (269)
Management of Massive Pulmonary Embolism (2001) (267)
Risk factors for pulmonary embolism. The Framingham Study. (1983) (250)
Cancer and venous thromboembolism. (2005) (246)
Thrombosis during pregnancy and the postpartum period. (2005) (246)
Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. (1984) (244)
Decreased HDL2 and HDL3 Cholesterol, Apo A‐I and Apo A‐II, and Increased Risk of Myocardial Infarction (1992) (236)
A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial. (2018) (235)
Effect of computerized clinical decision support on the use and yield of CT pulmonary angiography in the emergency department. (2012) (230)
New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment. (2000) (225)
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. (2008) (222)
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation (2016) (220)
The acutely decompensated right ventricle: pathways for diagnosis and management. (2005) (214)
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF (2016) (214)
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism☆ (2003) (212)
Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review (2005) (212)
Chronic thromboembolic pulmonary hypertension. (2011) (211)
Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials. (1982) (208)
Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development (2014) (204)
Pulmonary Embolism (1999) (204)
Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. (1992) (202)
Predictive Value of Computed Tomography in Acute Pulmonary Embolism: Systematic Review and Meta-analysis. (2015) (201)
Risk factors for venous thromboembolism. (2010) (199)
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). (2012) (196)
Chest radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry. (2000) (195)
Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. (2001) (195)
Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers (2014) (195)
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research (2020) (194)
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study (2015) (194)
Spiral Computed Tomography for Acute Pulmonary Embolism (2004) (192)
Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. (2002) (191)
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19 (2020) (189)
Prevention and treatment of venous thromboembolism--International Consensus Statement. (2013) (188)
Venous thromboembolic disease. (2011) (188)
ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATOR (1986) (185)
Venous thromboembolism: epidemiology and magnitude of the problem. (2012) (184)
The accuracy of the enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary embolism: a meta-analysis. (2002) (183)
CT signs of right ventricular dysfunction: prognostic role in acute pulmonary embolism. (2011) (183)
Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. (1997) (182)
Intermittent pneumatic compression and deep vein thrombosis prevention (2005) (179)
Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging (2007) (174)
Prevalence of deep venous thrombosis among patients in medical intensive care. (1996) (173)
Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group. (1994) (172)
Prevalence of deep venous thrombosis among patients in medical intensive care (1995) (172)
More than an anticoagulant: Do heparins have direct anti-inflammatory effects? (2016) (171)
Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. (1996) (171)
Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis. (2013) (169)
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018. (2018) (169)
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients (2004) (164)
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism (2013) (159)
Acute pulmonary embolism: part I: epidemiology and diagnosis. (2006) (157)
Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. (1995) (157)
Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. (2005) (155)
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD‐AF, ORBIT‐AF I, and ORBIT‐AF II registries (2017) (154)
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer (2015) (154)
Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. (1990) (153)
Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. (1990) (153)
Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study (1992) (151)
Low-molecular-weight heparin and mortality in acutely ill medical patients. (2011) (150)
Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. (2006) (150)
Acute pulmonary embolism: part II: risk stratification, treatment, and prevention. (2003) (148)
Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism. (1994) (148)
Quantitative plasma D-dimer levels among patients undergoing pulmonary angiography for suspected pulmonary embolism. (1993) (142)
Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. (1997) (139)
An overview of contemporary etiologies of congestive heart failure. (1991) (139)
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015. (2015) (138)
Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator. (1987) (138)
Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolism. (2002) (135)
Patients With Cancer (2013) (132)
Effects of Random Allocation to Vitamin E Supplementation on the Occurrence of Venous Thromboembolism: Report From the Women’s Health Study (2007) (127)
Prevention and Treatment of Venous Thromboembolism (2013) (125)
Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. (2004) (125)
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19 (2021) (124)
Opinions regarding the diagnosis and management of venous thromboembolic disease. ACCP Consensus Committee on Pulmonary Embolism. American College of Chest Physicians. (1998) (122)
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry (2016) (122)
Pulmonary embolism: risk assessment and management. (2012) (119)
Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians. (1997) (118)
Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy. (2016) (117)
Cognitive Function and Anticoagulation Control in Patients With Atrial Fibrillation (2010) (115)
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. (2006) (115)
Warfarin dosing and cytochrome P450 2C9 polymorphisms (2004) (115)
Inferior Vena Cava Filters to Prevent Pulmonary Embolism: Systematic Review and Meta-Analysis. (2017) (113)
Management of submassive pulmonary embolism. (2010) (112)
Surgical Embolectomy for Acute Massive and Submassive Pulmonary Embolism in a Series of 115 Patients. (2015) (111)
Role of Computerized Physician Order Entry Systems in Facilitating Medication Errors (2005) (111)
Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. (2005) (111)
Acute pulmonary embolism: part II: treatment and prophylaxis. (2006) (110)
Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial. (2005) (108)
Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis: Analysis From a Stratified Multicenter Randomized Trial (2019) (106)
Venous thromboembolism and atherothrombosis: an integrated approach. (2010) (106)
Hospital costs of acute pulmonary embolism. (2013) (104)
Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients (2010) (103)
Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent. (2007) (102)
A Randomized Trial of Dabigatran Versus Warfarin in the Treatment of Acute Venous Thromboembolism (RE-COVER II) (2011) (101)
Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding. (2006) (99)
Prospective Study of BMI and the Risk of Pulmonary Embolism in Women (2009) (99)
Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. (1994) (96)
Recovery of regional right ventricular function after thrombolysis for pulmonary embolism. (1999) (93)
Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. (1991) (92)
Diagnosis, treatment, and prevention of pulmonary embolism : report of the WHO/international society and federation of cardiology task force (1992) (92)
Delays in diagnosis of deep vein thrombosis and pulmonary embolism. (2005) (92)
Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden. (1996) (91)
Anticoagulation-associated adverse drug events. (2011) (91)
Physician Alerts to Prevent Symptomatic Venous Thromboembolism in Hospitalized Patients (2009) (90)
The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification (2017) (89)
Intraarterial thrombolysis of lower extremity occlusions: prospective, randomized comparison of forced periodic infusion and conventional slow continuous infusion. (1993) (89)
G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism. (2001) (89)
The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study. (2014) (89)
Prevention of venous thrombosis after coronary artery bypass surgery (a randomized trial comparing two mechanical prophylaxis strategies). (1995) (88)
Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (2015) (87)
Clinical gestalt and the diagnosis of pulmonary embolism: does experience matter? (2004) (87)
Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients (2005) (84)
2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology (2016) (84)
Hormonal factors and risk of recurrent venous thrombosis: the Prevention of Recurrent Venous Thromboembolism trial (2006) (84)
Baseline Fibrinolytic State and the Risk of Future Venous Thrombosis: A Prospective Study of Endogenous Tissue‐Type Plasminogen Activator and Plasminogen Activator Inhibitor (1992) (83)
Clinical suspicion of autopsy-proven thrombotic and tumor pulmonary embolism in cancer patients. (1987) (83)
Major bleeding complications in a specialized anticoagulation service. (2005) (83)
D‐dimer, factor VIII coagulant activity, low‐intensity warfarin and the risk of recurrent venous thromboembolism (2006) (81)
Warfarin and Vascular Calcification. (2016) (81)
Venous thromboembolism in patients with diabetes mellitus. (2012) (81)
Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy (2010) (79)
Peripheral Artery Disease: Past, Present, and Future. (2019) (79)
Clinical uses of low-molecular-weight heparins. (1999) (79)
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation (2017) (78)
The International Cooperative Pulmonary Embolism Registry. (1995) (78)
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation (2018) (77)
Utility of leg ultrasonography in suspected symptomatic isolated calf deep venous thrombosis. (1995) (76)
Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation. (2009) (76)
Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. (1990) (75)
Venous thromboembolism in patients with active cancer (2007) (74)
Venous Thromboembolism Occurs Frequently in Patients Undergoing Brain Tumor Surgery Despite Prophylaxis (1999) (74)
Venous thromboembolism in children. (2006) (73)
Performance of Wells Score for Deep Vein Thrombosis in the Inpatient Setting. (2015) (73)
Pulmonary Embolism and Deep Venous Thrombosis (1985) (73)
Integration of catheter thrombectomy into our armamentarium to treat acute pulmonary embolism. (1998) (73)
d-Dimer elevation and adverse outcomes (2014) (72)
Frequency of deep venous thrombosis in asymptomatic patients with coronary artery bypass grafts. (1991) (71)
Pulmonary embolism thrombolysis: a clarion call for international collaboration. (1992) (70)
Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. (2004) (69)
Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism. (1988) (69)
Medication errors associated with anticoagulant therapy in the hospital. (2004) (69)
Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. (2004) (68)
Pulmonary embolism thrombolysis: broadening the paradigm for its administration. (1997) (68)
Measurement of infarct size using single photon emission computed tomography and technetium-99m pyrophosphate: a description of the method and comparison with patient prognosis. (1982) (67)
Time-resolved MR angiography: a primary screening examination of patients with suspected pulmonary embolism and contraindications to administration of iodinated contrast material. (2007) (67)
Thrombolysis for pulmonary embolism. (1991) (66)
Long-term complications of medical patients with hospitalacquired venous thromboembolism (2009) (64)
The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. (2005) (64)
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™ (2016) (63)
Anticoagulation in dilated cardiomyopathy. (1998) (63)
Fibrinolysis for acute pulmonary embolism (2010) (63)
Comparison of ECG-gated versus non-gated CT ventricular measurements in thirty patients with acute pulmonary embolism (2008) (63)
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants. (2020) (63)
Axial and reformatted four-chamber right ventricle-to-left ventricle diameter ratios on pulmonary CT angiography as predictors of death after acute pulmonary embolism. (2012) (63)
Comparison of delay times to hospital presentation for physicians and nonphysicians with acute myocardial infarction. (1992) (62)
Prevention of venous thromboembolism among hospitalized medical patients. (2005) (61)
Electronic alerts for hospitalized high-VTE risk patients not receiving prophylaxis: a cohort study (2008) (61)
Regional Right Ventricular Strain Pattern in Patients with Acute Pulmonary Embolism (2012) (61)
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban) (2017) (60)
Physical exercise and reduced risk of nonfatal myocardial infarction. (1995) (60)
Adherence to pharmacological thromboprophylaxis orders in hospitalized patients. (2010) (60)
Physical inactivity and idiopathic pulmonary embolism in women: prospective study (2011) (60)
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies (2020) (60)
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database (2020) (60)
Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism (2003) (59)
The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study. (1991) (59)
Therapy and outcomes in massive pulmonary embolism from the Emergency Medicine Pulmonary Embolism in the Real World Registry. (2012) (59)
Thrombolytic therapy for patients with pulmonary embolism who are hemodynamically stable but have right ventricular dysfunction: pro. (2005) (58)
Impact of smart infusion technology on administration of anticoagulants (unfractionated Heparin, Argatroban, Lepirudin, and Bivalirudin). (2007) (58)
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry (2018) (58)
Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010. (2016) (57)
Prevention of Deep Vein Thrombosis and Pulmonary Embolism (2004) (56)
Pooled Analyses of Randomized Trials of Streptokinase and Heparin in Phlebographically Documented Acute Deep Venous Thrombosis (1984) (56)
Imaging in acute pulmonary embolism with special clinical scenarios. (2010) (56)
Venous thromboembolic events in hospitalised medical patients (2009) (55)
Contemporary pulmonary embolism thrombolysis. (1998) (55)
Pulmonary Embolism Hospitalization, Readmission, and Mortality Rates in US Older Adults, 1999-2015. (2019) (55)
Diagnosis, treatment, and prevention of pulmonary embolism. Report of the WHO/International Society and Federation of Cardiology Task Force. (1993) (55)
Thromboprophylaxis with dalteparin in medical patients: which patients benefit? (2007) (53)
Interval increase in right-left ventricular diameter ratios at CT as a predictor of 30-day mortality after acute pulmonary embolism: initial experience. (2008) (53)
Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation: Results From the GARFIELD-AF Registry (2019) (53)
Time trends in warfarin-associated hemorrhage. (2004) (52)
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial (2021) (52)
Assessing the prognosis of acute pulmonary embolism: tricks of the trade. (2008) (52)
Routine pelvic and lower extremity CT venography in patients undergoing pulmonary CT angiography. (2008) (51)
Cost analysis of "bridging therapy" with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation. (2004) (51)
Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels. (2012) (51)
Thrombolytic therapy of acute pulmonary embolism: current status and future potential. (1987) (51)
Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation (1996) (51)
Cardiovascular risk stratification of pulmonary embolism. (1996) (51)
Prospective study of diet and venous thromboembolism in US women and men. (2012) (51)
Global Anticoagulant Registry in the Field – Venous Thromboembolism (GARFIELD-VTE) (2016) (50)
Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital: the Brigham and Women's Hospital DVT registry. (1996) (50)
Thrombolysis in pulmonary embolism: a large-scale clinical trial is overdue. (2001) (49)
The safety and efficacy of full‐ versus reduced‐dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended‐Duration Betrixaban (APEX) trial (2017) (49)
Short-term response to thrombolytic therapy in deep venous thrombosis: predictive value of venographic appearance. (1992) (49)
The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage. (2004) (49)
Heparin-induced thrombocytopenia (HIT): Clinical and economic outcomes (2008) (48)
International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle. (2004) (48)
Acute pulmonary embolism: don't ignore the platelet. (2002) (48)
Time trends in hospital mortality and diagnosis of pulmonary embolism. (1982) (47)
Adverse drug events in hospitalized cardiac patients. (2007) (46)
Effect of Low-Dose Aspirin on the Occurrence of Venous Thromboembolism (2007) (46)
Patient education program for venous thromboembolism prevention in hospitalized patients. (2012) (45)
Pulmonary embolism in heart failure. (2008) (44)
Thrombolysis for pulmonary embolism. (2002) (44)
Anticoagulants and Transaminase Elevation (2006) (43)
Optimal strategy for diagnosis and treatment of pulmonary embolism due to right atrial thrombus. (1988) (43)
Venous thromboembolic disease. Clinical practice guidelines in oncology. (2006) (43)
Computerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyond. (2009) (43)
Advanced treatment strategies for acute pulmonary embolism, including thrombolysis and embolectomy (2009) (42)
Plasma renin substrate, renin activity, and aldosterone levels in a sample of oral contraceptive users from a community survey. (1984) (42)
Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel (2016) (42)
Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy (2017) (42)
Chronic venous insufficiency: mechanisms and management. (1996) (42)
Venous Thromboembolism Risk and Prophylaxis in the Acute Care Hospital Setting (ENDORSE Survey): Findings in Surgical Patients (2010) (41)
The contribution of the subjective component of the Canadian Pulmonary Embolism Score to the overall score in emergency department patients. (2005) (41)
Influence Of Concomitant NSAID Or ASA On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II (2013) (41)
Deep vein thrombosis in patients with chronic kidney disease (2008) (41)
Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation (2005) (40)
Venous thromboembolism in heart failure: preventable deaths during and after hospitalization. (2011) (40)
Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning. (1988) (40)
Risk of Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study. (2018) (40)
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial (2018) (40)
Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial (2018) (39)
Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination (2008) (39)
Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism (2005) (39)
Sulodexide in venous disease (2018) (39)
Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. (2021) (38)
Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry (2019) (37)
Prevention of pulmonary embolism in general surgery patients. (2007) (37)
Surgical pulmonary embolectomy: the resurrection of an almost discarded operation. (2013) (37)
Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial. (2007) (37)
Treatment of right atrial thrombus with urokinase. (1988) (37)
Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19 (2021) (37)
Risk stratification of acute pulmonary embolism. (2006) (37)
Multislice computed tomography for pulmonary embolism--a technological marvel. (2005) (36)
Gastrointestinal complications of dual antiplatelet therapy. (2006) (36)
Epidemiology of pulmonary embolism. (2001) (35)
Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies (2010) (35)
Venous thromboembolism in the intensive care unit: the last frontier for prophylaxis. (1998) (35)
Biochemical markers of compliance in the Physicians' Health Study. (1990) (35)
Heart failure in patients with deep vein thrombosis. (2008) (35)
High utilization rate of vena cava filters in deep vein thrombosis (2005) (35)
Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis (2020) (35)
Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy. (1987) (35)
Ovarian vein thrombosis. (1993) (34)
Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomy. (2002) (34)
Percutaneous mechanical thrombectomy for acute pulmonary embolism: a double-edged sword. (2007) (33)
Tissue plasminogen activator in acute pulmonary embolism. (1989) (33)
Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis (2019) (32)
Desmoteplase in acute massive pulmonary thromboembolism (2009) (32)
Contemporary pulmonary embolism thrombolysis. (1995) (32)
Risk factors for major bleeding in the SEATTLE II trial (2017) (32)
Venous thromboembolism in patients with chronic obstructive pulmonary disease. (2012) (32)
Benefit of Extended Maintenance Therapy for Venous Thromboembolism with Dabigatran Etexilate Is Maintained Over 1 Year of Post-Treatment Follow-up (2012) (32)
Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective. (2005) (32)
Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry (2019) (32)
Thrombolysis in venous thromboembolism. An international perspective. (1990) (31)
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19 (2021) (31)
Pulmonary embolism presenting as seizures. (1997) (31)
2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology (2016) (31)
Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator. (1987) (30)
Elevation of troponin I levels in patients without evidence of myocardial injury. (1997) (30)
Venous thromboembolism in patients with symptomatic atherosclerosis (2011) (30)
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE (2020) (30)
Pulmonary embolism after coronary artery bypass grafting. (2004) (29)
Controversies in Diagnosis of Pulmonary Embolism (2011) (29)
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. (1995) (29)
Thrombolytic therapy in venous thromboembolism. Clinical trials and current indications. (1995) (29)
Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT). (2019) (28)
Dementia and Atrial Fibrillation: Pathophysiological Mechanisms and Therapeutic Implications. (2018) (28)
Controversies surrounding long-term anticoagulation of very elderly patients in atrial fibrillation. (1998) (28)
Two trials of reduced bolus alteplase in the treatment of pulmonary embolism. An overview. (1994) (28)
Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis. (2020) (28)
Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy. (2018) (28)
Cardiac biomarkers in pulmonary embolism. (2003) (28)
Preventing pulmonary embolism and deep vein thrombosis: a ‘call to action’ for vascular medicine specialists (2007) (28)
Optimal duration of anticoagulation after venous thromboembolism. (2011) (27)
Evolving concepts in thrombolytic therapy for pulmonary embolism. (1992) (27)
Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial (2019) (27)
Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE. (2010) (27)
Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial. (1996) (27)
Attenuation over 24 hours of the efficacy of thrombolysis of pulmonary embolism among patients with cancer. (1997) (27)
Modern treatment of pulmonary embolism (2002) (27)
Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients (2019) (27)
Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry (2017) (27)
Thrombosis and Thromboembolism (2002) (27)
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents (2020) (26)
Diagnosis of deep venous thrombosis. (2000) (26)
A critical pathway to evaluate suspected deep vein thrombosis. (1995) (26)
Research Priorities in Submassive Pulmonary Embolism: Proceedings from a Multidisciplinary Research Consensus Panel. (2016) (26)
Prevention of Recurrent Idiopathic Venous Thromboembolism (2004) (26)
Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation (2011) (26)
Cardiology patient pages. Pulmonary embolism and deep vein thrombosis. (2002) (26)
Treatment of acute pulmonary embolism with dabigatran versus warfarin (2016) (26)
Decreased HDL 2 and HDL 3 Cholesterol , Apo A-I and Apo AII , and Increased Risk of Myocardial Infarction (2005) (25)
Venous thromboembolism in patients undergoing surgery: Low rates of prophylaxis and high rates of filter insertion (2007) (25)
Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial (2017) (25)
Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis (2017) (25)
Bleeding events with dabigatran or warfarin in patients with venous thromboembolism (2016) (25)
Selection of patients with acute pulmonary embolism for thrombolytic therapy. Thrombolysis in pulmonary embolism (TIPE) patient survey. The TIPE Investigators. (1989) (24)
Death from high‐risk prostate cancer versus cardiovascular mortality with hormonal therapy (2013) (24)
Comparison of a single end point to determine optimal initial warfarin dosing (5 mg versus 10 mg) for venous thromboembolism. (2006) (24)
"Bridging" and mechanical heart valves: perils, promises, and predictions. (2006) (24)
Gender differences in the administration of prophylaxis to prevent deep venous thrombosis (2005) (24)
Randomized clinical trials of transdermal nitroglycerin systems for the treatment of angina: a meta-analysis. (1988) (24)
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II. (2017) (24)
Pulmonary embolism death rates. (1988) (24)
Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study. (2018) (24)
Clinical overview of venous thromboembolism (1998) (23)
Abbreviated hospitalization for deep venous thrombosis with the use of ardeparin. (1998) (23)
Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study (2015) (23)
Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the Prospective Evaluation of Dalteparin efficacy for Prevention of Venous Thromboembolism in Immobilized Patients Trial (the PREVENT study) (2002) (23)
Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry (2019) (23)
Expanding anticoagulation management services to include direct oral anticoagulants (2018) (23)
Frequency of pulmonary embolism in patients with low-probability lung scan and negative lower extremity venous ultrasound. (1999) (23)
Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial (2019) (23)
Treatment of pulmonary thromboembolism. (1999) (22)
Mechanical catheter intervention in massive pulmonary embolism: proof of concept. (2008) (22)
DVT Prevention: what is happening in the "real world"? (2003) (22)
Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats. (2020) (22)
Randomized trial of physician alerts for thromboprophylaxis after discharge. (2013) (22)
Late venous thromboembolic disease after radical prostatectomy: effect of risk factors, warfarin and early discharge. (1997) (22)
Symptomatic event reduction with extended‐duration betrixaban in acute medically ill hospitalized patients (2017) (21)
Shortened hospitalization by means of adjusted-dose subcutaneous heparin for deep venous thrombosis. (1996) (21)
Pulmonary embolic disease: diagnosis, pathophysiologic aspects, and treatment with thrombolytic therapy. (1993) (21)
A critical pathway to treat proximal lower-extremity deep vein thrombosis. (1996) (21)
Lung scan evaluation of thrombolytic therapy for pulmonary embolism. (1995) (21)
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry. (2019) (21)
Machine learning to predict venous thrombosis in acutely ill medical patients (2020) (21)
Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial). (2018) (21)
Laboratory thrombophilias and venous thromboembolism (2002) (20)
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy (2019) (20)
Complications of heparin therapy after total joint arthroplasty. (1990) (20)
Efficacy and safety of repeated boluses of urokinase in the treatment of deep venous thrombosis. (1994) (20)
Gender comparisons in pulmonary embolism (results from the International Cooperative Pulmonary Embolism Registry [ICOPER]). (2002) (20)
Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the Apex Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial) (2018) (20)
Treatment of Blood Clots (2002) (20)
NOACs for treatment of venous thromboembolism in clinical practice (2017) (20)
A free-floating approach to filters. (1997) (20)
Improving clinical effectiveness in thromboprophylaxis for hospitalized medical patients. (2009) (20)
Four key questions surrounding thrombolytic therapy for submassive pulmonary embolism (2016) (20)
Clinical Characteristics of Nonfatal Myocardial Infarction Among Individuals on Prophylactic Low‐Dose Aspirin Therapy (1991) (20)
Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients. (2017) (19)
Underutilization of Anticoagulation for Stroke Prevention in Atrial Fibrillation. (2016) (19)
Low molecular weight heparin versus minidose unfractionated heparin for prophylaxis against venous thromboembolism in Medical Intensive Care Unit patients A randomized controlled trial (2000) (19)
North American Thrombosis Forum, AF Action Initiative Consensus Document. (2016) (19)
Management of deep venous thrombosis and pulmonary embolism. (2000) (19)
Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy. (2004) (19)
Pulmonary embolism (2004) (19)
Cancer-Associated Venous Thromboembolic Disease , Version 2 . 2018 Featured Updates to the NCCN Guidelines (2018) (18)
Physician alerts to prevent venous thromboembolism (2010) (18)
Pulse-spray thrombolysis: the "careful analysis". (1994) (18)
Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation (2020) (18)
Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism. (2014) (18)
Venous thromboembolism risk among hospitalized patients: Magnitude of the risk is staggering (2007) (18)
The Creating an Optimal Warfarin Nomogram (CROWN) Study (2011) (17)
Venous Thromboembolism in Hospitalized Patients With Active Cancer (2013) (17)
Pulmonary embolism. (1998) (17)
Inferior Vena Cava Filters (2013) (17)
Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry. (2021) (17)
Ultrasound-facilitated, catheter-directed thrombolysis versus anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study. (2022) (17)
Thrombolytic therapy in pulmonary embolism. (2001) (16)
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events (2019) (16)
Let's Stop Dichotomizing Venous Thromboembolism as Provoked or Unprovoked. (2018) (16)
A contemporary approach to thrombolytic therapy for pulmonary embolism (2000) (16)
Rescue percutaneous coronary intervention immediately following coronary artery bypass grafting. (2001) (16)
Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial. (2013) (16)
Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial (2017) (16)
Cardiology patient pages. A patient's guide to taking coumadin/warfarin. (2009) (16)
When academic research organizations and clinical research organizations disagree: Processes to minimize discrepancies prior to unblinding of randomized trials. (2017) (16)
How to select patients with deep vein thrombosis for tPA therapy. (1989) (16)
Global reporting of pulmonary embolism–related deaths in the World Health Organization mortality database: Vital registration data from 123 countries (2021) (16)
Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt‐PA for pulmonary embolism (1997) (15)
Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy (2019) (15)
N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy (2017) (15)
Low Intensity Warfarin Anticoagulation is Safe and Effective as a Long-Term Venous Thromboembolism Prevention Strategy (2006) (15)
Uses of low-molecular-weight heparin. (1995) (15)
Cost benefit of intermittent pneumatic compression for venous thromboembolism prophylaxis in general surgery. (2008) (15)
Recent advances in the diagnosis and lytic therapy of pulmonary embolism. (1991) (15)
Detection of pulmonary perfusion defects by single photon emission computed tomography (SPECT). (1988) (15)
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate (2016) (15)
Gynecology and Obstetrics (2013) (15)
Deep Vein Thrombosis in Orthopedic Surgery (2009) (15)
The perils of D-dimer in the medical intensive care unit. (2000) (15)
Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE. (2020) (15)
Prescription of fondaparinux in hospitalised patients (2009) (14)
Outpatient venous thromboembolism: a common but often preventable public health threat. (2007) (14)
Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism (2016) (14)
Fixed low-dose versus adjusted higher-dose warfarin following orthopedic surgery. A randomized prospective trial. (1994) (14)
Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease (2020) (14)
Deep-Vein Thrombosis in the Elderly (2008) (14)
Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy (2019) (14)
Diagnosis of pulmonary embolism. (2000) (14)
Intermittent pneumatic compression and deep vein thrombosis prevention in postoperative patients (2006) (14)
Heparin-induced thrombocytopenia. (2006) (14)
Pulmonary embolism for cardiologists. (1997) (14)
The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage (2004) (14)
Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials (2020) (13)
Treatment of acute, symptomatic, proximal deep vein thrombosis with the oral, direct Factor Xa inhibitor rivaroxaban (BAY 59-7939) - the ODIXa-DVT dose-ranging study (2006) (13)
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II (2017) (13)
Clinically significant venous thromboembolism after gynecologic surgery. (1999) (13)
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative. (2020) (13)
New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF (2019) (13)
Cancer and venous thromboembolism. (1987) (13)
Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism. (2003) (13)
Chest CT assessment following thrombolysis or surgical embolectomy for acute pulmonary embolism (2005) (13)
Once-daily fondaparinux monotherapy without warfarin for long-term treatment of venous thromboembolism (2007) (13)
The probability of pulmonary embolism is a function of the diagnoses considered most likely before testing. (2006) (13)
Interruption of the inferior vena cava by clip or filter. (1984) (13)
New AI Prediction Model Using Serial PT-INR Measurements in AF Patients on VKAs: GARFIELD-AF. (2019) (13)
Medication Use Evaluation: Pharmacist Rubric for Performance Improvement (2014) (13)
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study (2016) (13)
Race and venous thromboembolism: nature or nurture? (2014) (13)
PEITHO Long-Term Outcomes Study: Data Disrupt Dogma. (2017) (12)
Trends in Perioperative Venous Thromboembolism Associated with Major Noncardiac Surgery (2017) (12)
Influence of Thrombophilia on the Efficacy of Dabigatran Versus Warfarin for the Extended Treatment of Acute Venous Thromboembolism in RE-MEDY™ (2014) (12)
Interruption of the inferior vena cava for prevention of pulmonary embolism: transvenous filter devices. (1989) (12)
The critical pathways of an anticoagulation service. (2003) (12)
Pulmonary embolism thrombolysis: Do we need another agent? (1999) (12)
Constrictive pericarditis: a case requiring pericardiectomy following Dressler's postmyocardial infarction syndrome. (1981) (12)
Variation in the management of deep vein thrombosis: implications for the potential impact of a critical pathway. (1996) (12)
Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials (2021) (11)
Venous Thromboembolism in Heart Failure Patients: Pathophysiology, Predictability, Prevention. (2020) (11)
Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge. (2011) (11)
Pulmonary embolism associated with olanzapine (2006) (11)
Prevention by nifedipine of cold pressor-induced decrease in left ventricular ejection fraction. (1983) (11)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-2004. A 42-year-old woman with cardiac arrest several weeks after an ankle fracture. (2004) (11)
Efficacy and Safety of Fixed Low-Dose Dalteparin in Preventing Venous Thromboembolism Among Obese or Elderly Hospitalized Patients (2005) (11)
Optimal Duration of Anticoagulation After Venous Thromboembolism: Fixed and Evidence-Based, or Flexible and Personalized? (2009) (11)
Development of Sex-Stratified Prediction Models for Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study (2020) (11)
Hospital Budget Implications of Substituting Dabigatran for Warfarin in an Anticoagulation Service (2012) (11)
Unsolved issues in the treatment of pulmonary embolism. (2001) (11)
Association of ABO blood group type with cardiovascular events in COVID-19 (2021) (11)
Acute pulmonary embolism treated with thrombolytic agents: current status of tPA and future implications for emergency medicine. (1988) (11)
Bleeding time and other laboratory tests to monitor the safety and efficacy of thrombolytic therapy. (1990) (11)
Superficial Vein Thrombosis (2013) (11)
Deep Venous Thrombosis: Early Discharge Strategies and Outpatient Management (1999) (10)
Treatment for Patients With Cancer (2013) (10)
Venous Thromboembolism and Atherothrombosis (2010) (10)
Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial. (2019) (10)
Venous thromboembolism prophylaxis: Quality, location (hospital vs. home), and duration (2009) (10)
Comparative effectiveness of oral anticoagulants in everyday practice (2021) (10)
11 Thrombolytic therapy for venous thromboembolism (1990) (10)
Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a protocol amendment. (2015) (10)
Eradication of hospital-acquired venous thromboembolism (2010) (10)
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE (2021) (10)
Intraoperative detection of pulmonary thromboemboli with epicardial echocardiography. (1999) (10)
Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry (2019) (10)
Venous thromboembolism guidebook. (2002) (10)
Anticoagulation and enoxaparin use in patients with prosthetic heart valves and/or pregnancy. Report and Recommendations of the Anticoagulation in Prosthetic Valves and Pregnancy Consensus Report (APPCR) Panel and Scientific Roundtable (2002) (10)
Medicare's new regulations for deep vein thrombosis as a "never event": wise or worrisome? (2009) (10)
European Atherosclerosis Society screening recommendations for lipoprotein(a) and high-sensitivity C-reactive protein: double standard or failure of evidence-based medicine? (2010) (10)
Venous thrombosis: prevention, treatment, and relationship to paradoxical embolization. (1994) (10)
Association of Inferior Vena Cava Filter Use With Mortality Rates in Older Adults With Acute Pulmonary Embolism (2019) (10)
Isolated Calf Vein Thrombosis (2001) (10)
Abstract 18594: Efficacy of Dabigatran versus Warfarin in Patients With Acute Venous Thromboembolism and Thrombophilia: A Pooled Analysis of RE-COVER™ and RE-COVER™ II (2014) (10)
Thrombolysis in submassive pulmonary embolism (2004) (10)
Percutaneous mechanical thrombectomy for massive pulmonary embolism: Improve safety and efficacy by sharing information (2007) (10)
Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multi-center Randomized Trial. (2020) (10)
Catheter-directed thrombolysis for giant right atrial thrombus. (2010) (10)
Cardiology Patient Page: inflammation and myocardial infarction. (2014) (9)
Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial (2018) (9)
Once Daily Enoxaparin for Outpatient Treatment of Acute Venous Thromboembolism: A Case-control Study (2008) (9)
Performance of Wells Score for Deep Vein Thrombosis in the Inpatient Setting (2016) (9)
Dabigatran Etexilate Versus Warfarin in the Treatment of Venous Thromboembolism. (2009) (9)
One-Year Echocardiographic, Functional, and Quality of Life Outcomes After Ultrasound-Facilitated Catheter-Based Fibrinolysis for Pulmonary Embolism (2020) (9)
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™ (2017) (9)
Use of Prophylaxis for Prevention of Venous Thromboembolism in Patients with Isolated Foot or Ankle Surgery: A Systematic Review and Meta-Analysis (2019) (9)
Venous thromboembolism prophylaxis in the craniotomy patient: an editorial. (1998) (9)
Paradoxical embolism. (2010) (9)
The current role of thrombolytic therapy for pulmonary embolism. (2000) (9)
Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer (2017) (9)
Dalteparin sodium for the long-term management of venous thromboembolism in cancer patients. The DALTECAN Study (2013) (9)
Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients (2016) (9)
The Immunogenic Potential of Generic Version of Low-Molecular-Weight Heparins May Not be the Same as the Branded Products (2008) (9)
Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective (2020) (9)
Effectiveness and safety of long-term anticoagulation of patients >/=90 years of age with atrial fibrillation. (2002) (9)
UROKINASE VERSUS TISSUE PLASMINOGEN ACTIVATOR IN PULMONARY EMBOLISM (1988) (9)
Venous Thromboembolism Guidebook, fourth edition. (2003) (8)
Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study (2021) (8)
Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy (2017) (8)
PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients (2021) (8)
Program for the prevention of venous thromboembolism in high-risk orthopaedic patients. (1991) (8)
Outcomes in newly diagnosed atrial fibrillation and history of acute coronary syndromes: insights from GARFIELD-AF. (2019) (8)
Quantification and Significance of Pulmonary Vascular Volume in Predicting Response to Ultrasound-Facilitated, Catheter-Directed Fibrinolysis in Acute Pulmonary Embolism (SEATTLE-3D). (2019) (8)
Optimizing anticoagulant therapy in the management of pulmonary embolism. (1999) (8)
How chest CT for the diagnosis of pulmonary embolism (PE) has changed my professional life: reflections from a PE doctor. (2005) (8)
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). How we diagnose and treat deep vein thrombosis. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. (2004) (8)
Handbook for Venous Thromboembolism (2015) (8)
Selection Bias, Orthopaedic Style: Knowing What We Don't Know About Aspirin. (2019) (8)
Acute Stress Cardiomyopathy and Reversible Left Ventricular Dysfunction (8)
The Surgeon General's call to action exemplifies the role of advocacy in preventing venous thromboembolism. (2009) (8)
Risk Stratification Model: Lower-Extremity Ultrasonography for Hospitalized Patients with Suspected Deep Vein Thrombosis (2017) (8)
Conjunctive heparin therapy. Limitations of subcutaneous administration. (1992) (8)
Impact of Surgery Type and Co-Morbidities on Venous Thromboembolism prophylaxis Practices in Patients Undergoing Major Surgical Procedures in Acute Care Hospitals Worldwide: A Subanalysis of Data from the ENDORSE Survey (2008) (8)
Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE. (2021) (8)
Low sensitivity of plasma DNA in screening for pulmonary embolism. (1982) (8)
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE (2021) (8)
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry (2018) (8)
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry (2018) (8)
Isolated calf vein thrombosis: comparison of MR venography and conventional venography after initial sonography in symptomatic patients. (2001) (8)
Requiem for Liberalizing Indications for Vena Caval Filters? (2016) (8)
Use of novel antithrombotic agents for COVID‐19: Systematic summary of ongoing randomized controlled trials (2021) (8)
Initiation of anticoagulation after cardiac surgery: a prospective cohort study of efficacy, safety, and cost with low molecular weight heparin bridging in lieu of continuous intravenous unfractionated heparin (2002) (8)
Diagnosis of acute pulmonary embolism: always be vigilant. (2007) (7)
Periprocedural Management of Antithrombotic Therapy and Use of Bridging Anticoagulation (2008) (7)
Rapidly progressing dyspnea associated with a mass in the right side of the heart. (1995) (7)
Venous Thromboembolism in Patients With Prior Stroke (2014) (7)
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review. (2022) (7)
Prolonged bleeding time as a marker of venous clot lysis during streptokinase therapy. (1991) (7)
Profile of Patients Diagnosed with Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study. (2020) (7)
Acute Pulmonary Embolism: Risk Stratification (2006) (7)
Periprocedural management of the chronically anticoagulated patient: critical pathways for bridging therapy. (2003) (7)
Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement (2001) (7)
The bleeding time: its potential utility among patients receiving thrombolytic therapy. (1990) (7)
Oral and Poster Presentations (2003) (7)
Prophylaxis of venous thrombosis (2001) (7)
Diagnosis and Anticoagulant Treatment * (2013) (7)
Tissue plasminogen activator and acute pulmonary embolism (1988) (7)
Predictors of Treatment Response Following Ultrasound-Facilitated Catheter-Directed Thrombolysis for Submassive and Massive Pulmonary Embolism (2020) (7)
Administration of epinephrine by emergency medical technicians. (2000) (7)
Fine-tuning risk stratification for acute pulmonary embolism with cardiac biomarkers. (2010) (7)
TPA versus urokinase in acute pulmonary embolism: results of a randomized controlled trial. (1989) (7)
Venous thromboembolism: an ounce of prevention. (2005) (6)
Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients. (2019) (6)
Abstract 12074: A Randomized, Open-Label, Multicenter Study of the Efficacy and Safety of Edoxaban Monotherapy versus Low-Molecular Weight Heparin/Warfarin in Patients With Symptomatic Deep Vein Thrombosis - Edoxaban Thrombus Reduction Imaging Study (eTRIS) (2014) (6)
Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD‐VTE (2021) (6)
The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE. (2021) (6)
Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial (2019) (6)
INCREASING INCIDENCE AND DECLINING MORTALITY AFTER CANCER-ASSOCIATED VENOUS THROMBOEMBOLISM - NATIONWIDE COHORT STUDY. (2021) (6)
Preventing DVT and PE in Hospitalized Patients: Improving a Successful Electronic Alert (2006) (6)
Medical patients. (2013) (6)
[Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France]. (2011) (6)
INAPPROPRIATE UTILIZATION OF ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLOBAL ANTICOAGULANT REGISTRY IN THE FIELD (GARFIELD) REGISTRY (2012) (6)
Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals (2019) (6)
CORONARY DISEASE Angioplasty or coronary bypass graft? (1993) (6)
Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation (2018) (6)
Thromboembolism Prophylaxis for Patients Discharged From the Hospital (2020) (6)
Gastrointestinal Complications After 3 Months of Dual Antiplatelet Therapy for Drug-eluting Stents as Assessed by Wireless Capsule Endoscopy (2009) (6)
Why do clinicians withhold anticoagulation in patients with atrial fibrillation and CHA2DS2-VASc score ≥ 2? (2019) (6)
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry (2021) (6)
Peripherally inserted central catheters: bigger is not necessarily better. (2011) (6)
Practice Guidelines for Noninvasive Positive-pressure Ventilation Help or Hindrance? (2003) (6)
Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism. (2004) (6)
Part I: Epidemiology and Diagnosis (2006) (6)
Anticoagulation and Hemostasis in Cardiac Surgical Patients (1994) (5)
Optimization of DOAC management services in a centralized anticoagulation clinic (2022) (5)
HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians (2010) (5)
Syncope (Fainting). (2016) (5)
Computed tomography angiography with pulmonary artery thrombus burden and right-to-left ventricular diameter ratio after pulmonary embolism (2017) (5)
Predictors of not initiating anticoagulation after incident venous thromboembolism: a Danish nationwide cohort study. (2020) (5)
Sunday, 26 August 2012 (2012) (5)
Net‐clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more (2019) (5)
Pulmonary embolism thrombolysis improves survival in massive pulmonary embolism (1995) (5)
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation (2021) (5)
INTRAVENOUS STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION - REPLY (1983) (5)
Cardiopulmonary diseases and cardiac tumors (1995) (5)
Impact of lung scanning on the management of suspected pulmonary embolism. (1987) (5)
External validation of the SOX‐PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis (2020) (5)
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis. (2015) (5)
The importance of rapidly treating patients with acute myocardial infarction. (1995) (5)
Women and Heart Attacks. (2016) (5)
Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic (2022) (5)
Effect of dabigatran on referrals to and switching from warfarin in two academic anticoagulation management services. (2013) (5)
Similarity in Presentation and Response to Thrombolysis Among Women and Men with Pulmonary Embolism (1998) (5)
"Acute Management of High- and Intermediate-Risk Pulmonary Embolism in Children: A Review". (2021) (5)
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials (2021) (5)
Catheter-directed, ultrasound-facilitated fibrinolysis in obese patients with massive and submassive pulmonary embolism (2018) (5)
Randomised comparative effectiveness trial of Pulmonary Embolism Prevention after hiP and kneE Replacement (PEPPER): the PEPPER trial protocol (2022) (4)
Thrombolysis in pulmonary embolism: State of the art (1992) (4)
Risk factors for the assessment of patients with pulmonary embolism. (2006) (4)
P2608Venous thromboembolism and the risk of recurrence: a Danish nationwide cohort study (2018) (4)
Prospective Study of Apixaban for Primary Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy (2018) (4)
Fatal warfarin-associated intracranial hemorrhage in atrial fibrillation inpatients (2018) (4)
Bolus and accelerated thrombolysis. Experimental observations and clinical management of myocardial infarction and pulmonary embolism. (1995) (4)
Abstract 12422: Influence of Polypharmacy on the Efficacy And Safety Of Dabigatran Versus Warfarin for the Treatment of Acute Venous Thromboembolism: A Pooled Analysis of RE-COVER® and RE-COVER II™ (2015) (4)
Counterpoint: should coagulopathy be repaired prior to central venous line insertion? No. (2012) (4)
Venous Thromboembolic Diseases (2012) (4)
Practical aspects of venous thromboembolism prevention : an overview (1994) (4)
Influence of Body Mass Index on Clinical Outcomes in Venous Thromboembolism: Insights from GARFIELD-VTE. (2021) (4)
International Normalized Ratio Increase Before Warfarin-Associated Hemorrhage (2016) (4)
Clinical and genetic aspects of cardiac myxomas (4)
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism (2021) (4)
Collaborative Cardiology and Pulmonary Management of Pulmonary Hypertension. (2019) (4)
Outpatient venous thromboembolism: the importance of optimum prophylaxis (2008) (4)
Laboratory parameters to monitor safety and efficacy during thrombolytic therapy. (1991) (4)
Improving Clinician Performance of Inpatient Venous Thromboembolism Risk Assessment and Prophylaxis (2013) (4)
Recombinant tissue plasminogen activator vs urokinase in acute pulmonary embolism (1989) (4)
Abstract 20393: Full-Dose Betrixaban Reduces Venous Thromboembolism-Related Mortality: An APEX Trial Substudy (2017) (4)
Association of Socioeconomic Disadvantage With Mortality and Readmissions Among Older Adults Hospitalized for Pulmonary Embolism in the United States (2021) (4)
P3569Impact of body mass index in newly diagnosed atrial fibrillation in the GARFIELD-AF registry (2017) (4)
: A Scientific Statement From the American Heart Association Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension Management of Massive and Submassive Pulmonary Embolism, Iliofemoral (2011) (3)
Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis in elderly patients with pulmonary embolism: A SEATTLE II sub-analysis (2017) (3)
Venous thromboembolism and risk of recurrence: a Danish nationwide cohort study (2018) (3)
Temporal trends in abdominal aortic aneurysmal disease: a nationwide cohort study on cardiovascular morbidity and medical cardioprotective therapy. (2022) (3)
Magnetic resonance angiography and venography were sensitive but had poor technical adequacy for diagnosing pulmonary embolism (2010) (3)
Abstract 19325: Betrixaban Reduces the Burden of Multiple Symptomatic Venous Thromboembolic Events in the APEX Trial (2016) (3)
for Venous Thromboembolism Prevention and Beyond Computerized Decision Support for the Cardiovascular Clinician: Applications (2009) (3)
What’s the “go to” anticoagulant for stroke prevention in atrial fibrillation? (2012) (3)
Trials That Matter: Can Patients with Venous Thromboembolism Be Treated with Fixed-Dose Subcutaneous Unfractionated Heparin? (2006) (3)
Managing pulmonary embolism. (1991) (3)
Pulmonary embolism diagnosis: Remember the history and physical exam (2008) (3)
The approach to massive pulmonary embolism. (2000) (3)
Cost-Effectiveness of Prevention and Treatment of VTE (2013) (3)
Cautionary Notes About Outpatient Treatment of Acute Pulmonary Embolism. (2018) (3)
Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial (2019) (3)
Direct Oral Anticoagulants vs Vitamin-K Antagonists in Thrombotic Antiphospholipid Syndrome: Meta-analysis of Randomized Controlled Trials. (2022) (3)
Venous Thromboembolism Guidebook: fifth edition. (2006) (3)
Contemporary use of laboratory tests to monitor safety and efficacy of thrombolytic therapy. (1992) (3)
DERIVATION OF A SIMPLIFIED PULMONARY EMBOLISM TRIAGE SCORE (PETS) TO PREDICT THE MORTALITY IN PATIENTS WITH CONFIRMED PULMONARY EMBOLISM FROM THE EMERGENCY MEDICINE PULMONARY EMBOLISM IN THE REAL WORLD REGISTRY (EMPEROR) (2012) (3)
Nonspecific elevation of troponin I (1998) (3)
Pulmonary embolism: segmental appearance of perfusion lung scan defects correlates with successful response to thrombolytic therapy. (1990) (3)
Chest computed tomography in the emergency department for suspected pulmonary embolism: it's time to practice what we preach. (2009) (3)
ECMO and Surgical Embolectomy: Two Potent Tools to Manage High-Risk Pulmonary Embolism. (2020) (3)
Emotional and psychological coping after venous thromboembolism (2009) (3)
Recent trends in use of inferior vena caval filters in US older adults with acute pulmonary embolism. (2019) (3)
Pulmonary Embolism in Patients With Syncope: Horse or Zebra? (2019) (3)
Echocardiography in the diagnosis and management of pulmonary embolism: a limerick. (2000) (3)
Pulmonary embolism in Black Americans (2010) (3)
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. (1992) (3)
Evaluation and optimization of prescribed concomitant antiplatelet and anticoagulation therapy centrally managed by an anticoagulation management service (2020) (3)
Risk Assessment to Predict Arterial and Venous Events in Patients Undergoing Percutaneous Coronary Intervention (2014) (3)
How the Results of a Randomized Trial of Catheter-Directed Thrombolysis versus Anticoagulation Alone for Submassive Pulmonary Embolism Would Affect Patient and Physician Decision Making: Report of an Online Survey (2019) (2)
3:00 PM Abstract No. 221 Optimum duration and dose of r-tPA with the acoustic pulse thrombolysisis procedure for ntermediate-risk (submassive) pulmonary embolism: OPTALYSE PE (2018) (2)
One-year outcomes in atrial fibrillation patients with versus without a previous stroke or transient ischaemic attack: findings from the international prospective GARFIELD registry (2013) (2)
Post-Hoc Analysis of RE-MEDY™ Demonstrates Significant Real-World Net Clinical Benefit for Dabigatran Versus Warfarin in Prevention of Secondary Venous Thromboembolism (2014) (2)
Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation (2018) (2)
Abstract 18357: Outcomes and Quality of Anticoagulant Control in Patients Newly Diagnosed with Non-valvular Atrial Fibrillation: Insights from the Worldwide GARFIELD Registry (2012) (2)
Preventing DVT in peripherally inserted central catheters. (2013) (2)
Acute myocardial infarction complicated by pulmonary embolism after thrombolytic therapy: problems in clinical management. (2005) (2)
European society of cardiology practice guidelines on acute pulmonary embolism: an American's commentary and personal perspectives. (2009) (2)
Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study (2021) (2)
Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study. (2022) (2)
General, Vascular, Bariatric, and Plastic Surgical Patients (2013) (2)
Inferior Vena Cava Filters to Prevent Pulmonary Embolism (2)
Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment. (2022) (2)
Surgical thrombectomy. (2013) (2)
Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry (2022) (2)
Fine-tuning the decision to initiate anticoagulation in atrial fibrillation by accounting for age and cardiovascular comorbidities. (2019) (2)
D-dimer and duration of anticoagulation. (2007) (2)
vte Prevention in Acutely Ill Medical Patients with Extended Duration Betrixaban - A Multicenter, Randomized, Active-controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Standard of Care Enoxaparin : ca02 (2016) (2)
HEPARIN INDUCED THROMBOCYTOPENIA: CLINICAL AND ECONOMIC OUTCOMES (2008) (2)
Extended-Duration Low-intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism: Design of the HI-PRO Trial. (2021) (2)
Cardiology Patient Page. Obstructive Sleep Apnea. (2015) (2)
Recent advances in the diagnosis and treatment of pulmonary thromboembolism (2003) (2)
Thrombolysis for Acute Pulmonary Embolism (2009) (2)
Newly diagnosed venous thromboembolism: Which patients will bleed after anticoagulation is initiated? (2008) (2)
4321Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial (2018) (2)
Catheter-directed thrombolysis for deep vein thrombosis: 2021 update (2021) (2)
Rationale supporting an “opt-out” policy for pharmacological venous thromboembolism prophylaxis in hospitalized medical patients (2013) (2)
Meta-Analysis Comparing Direct Oral Anticoagulants to Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer. (2020) (2)
Combined Modalities in Surgical Patients (2013) (2)
Management of acute pulmonary embolism (2007) (2)
Psychotropic drug use following venous thromboembolism versus diabetes mellitus in adolescence or young adulthood: a Danish nationwide cohort study (2019) (2)
1354The effect of non-recommended dosing of non-vitamin K antagonist oral anticoagulants (NOACs) on 1-year mortality in patients with newly diagnosed AF? Results from the GARFIELD-AF registry (2018) (2)
Recent advances in diagnosis of pulmonary embolism and deep venous thrombosis. (1988) (2)
1001-13 Gender bias against women: Men receive prophylaxis more often to prevent deep venous thrombosis (2004) (2)
Venous thromboembolism: how to prevent a tragedy. (1988) (2)
Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture. (2023) (2)
1,096 CANCER PATIENTS WITH DVT: LOWER PROPHYLAXIS RATES BUT MORE FREQUENT INFERIOR VENA CAVA FILTER INSERTION (2007) (2)
16 – Deep Vein Thrombosis and Pulmonary Embolism (2013) (2)
TREATMENT AND OUTCOMES OF PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ACCORDING TO GUIDELINE-DEFINED ANTICOAGULATION THRESHOLDS: RESULTS FROM THE GARFIELD-AF REGISTRY (2017) (2)
Improving healthcare delivery (1998) (2)
Prevention of venous thromboembolism: medical risk factors (1994) (2)
Use of enoxaparin in a patient with unstable angina. (2000) (1)
Orthopedic Surgery and Trauma (2013) (1)
Critical Care Medical Patients (2013) (1)
2239 : The Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of a Fatal Myocardial Infarction (2006) (1)
Left Ventricular Remodeling and Synchronized Biventricular Pacing in Advanced Heart Failure (2003) (1)
Modifiable Risk Factors for Pulmonary Embolism-Reply (1997) (1)
Clues to early death from symptomatic pulmonary embolism in subjects presenting as outpatients (2008) (1)
Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team (2022) (1)
Impact of NOAC and VKA on outcome of patients with newly diagnosed atrial fibrillation and diabetes: a report from the GARFIELD-AF registry (2021) (1)
Embolism after inferior vena cava filter mesh fragmentation. (2010) (1)
Venous Thromboembolism Risk and Prophylaxis Practices in Surgical Patients with Active Cancer: Findings from the Global ENDORSE Survey. (2008) (1)
The Problem and the Need for Prevention (2013) (1)
Thrombolytic Therapy (2013) (1)
Spontaneous remission and prolonged survival in postinfarction cardiomyopathy. (1986) (1)
Shortness of breath in the postoperative patient. (2004) (1)
PARADOXICAL PROTECTIVE EFFECT OF OBESITY ON THE RISK OF VENOUS THROMBOEMBOLISM: OBSERVATIONS FROM APEX TRIAL (2019) (1)
The effect of body mass index on clinical outcomes in patients with newly diagnosed atrial fibrillation in the GARFIELD-AF registry (2020) (1)
Stability of Alteplase for Catheter-Directed, Ultrasound-Facilitated Thrombolysis. (2021) (1)
Development of an Institutional Peri-procedural Management Guideline for Oral Anticoagulants. (2020) (1)
2160Performance of a machine learning model vs. IMPROVE score for VTE prediction in acute medically ill patients: insights from the APEX trial (2018) (1)
Key Questions to be Answered (2013) (1)
The Safety and Efficacy of Full Versus Reduced Dose Betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention with Extended Duration Betrixaban (APEX) Trial (2016) (1)
The design and rationale for the APEX study (Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban) (2013) (1)
A Review of Thrombolysis in Venous Thromboembolism With an Analysis of Alteplase Admixture Stability (2018) (1)
Abstract 20322: Extended-Duration Betrixaban Reduces the Risk of Venous Thromboembolism-Related Rehospitalization Among Acutely Ill Hospitalized Medical Patients: An APEX Trial Substudy (2017) (1)
1003-4 Echocardiographic Diagnosis of Acute Pulmonary Embolism: A Distinct Pattern of Abnormal Right Ventricular Wall Motion (1995) (1)
Risk of Recurrent Venous Thromboembolism in Selected Subgroups of Men: A Danish Nationwide Cohort Study (2022) (1)
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits Part 1 - Health Benefits (2006) (1)
P251Asymptomatic deep vein thrombosis in acutely ill medical patients: insights from the APEX trial (2018) (1)
Abstract 19875: IMPROVEDD Score: Addition of D-Dimer to the IMPROVE Score Improves Venous Thromboembolism Risk Stratification. An APEX Trial Substudy (2016) (1)
Cardiac Remodeling and Recovery: Lessons from Mechanical Ventricular Assist Devices (2004) (1)
Few predictors of massive deep vein thrombosis (2005) (1)
d-Dimer elevation and adverse outcomes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2015) (1)
Recognition and management of pulmonary embolism. (1993) (1)
Evaluation of Mitral Valve Regurgitation : Implications for Percutaneous Mitral Valve Repair (1)
Pulmonary embolism (2004) (1)
Early Detection and Management of Venous Thrombosis in Skull Base Surgery: Role of Routine Doppler Ultrasound Monitoring (2022) (1)
Cardiology patient pages. Treatment of blood clots. (2002) (1)
HOSPITAL COSTS OF ACUTE PULMONARY EMBOLISM (2012) (1)
A comparison of magnetic resonance venography (MRV), venous ultrasound and contrast venography in the diagnosis of isolated calf vein thrombosis (1998) (1)
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial. (2022) (1)
858-1 Risk factors for and inadequate prophylaxis against upper extremity deep vein thrombosis (2004) (1)
Thrombolytic therapy for venous thromboembolism. (1990) (1)
Abstract 23080: Increased Pulmonary Peripheral (But Not Central) Blood Flow Correlates With Decreased Right Ventricular Volume in Acute Pulmonary Embolism Treated With Ultrasound-Facilitated, Catheter-Directed Fibrinolysis (2017) (1)
PCV14 COST-EFFECTIVENESS OF THROMBOPROPHYLAXIS IN ACUTELY-ILL MEDICAL INPATIENTS (2002) (1)
Risk Factors for Bleeding in Patients with Nonvalvular Atrial Fibrillation Who Are Receiving Anticoagulant Therapy with Ximelagatran or Warfarin: Findings from the SPORTIF III and V Trials. (2004) (1)
Atrial fibrillation patients on warfarin and their transition to direct oral anticoagulants. (2020) (1)
Stroke risk factors and outcomes among hospitalized women with atrial fibrillation (2021) (1)
Tuesday, 28 August 2012 (2012) (1)
PULMONARY EMBOLISM HOSPITALIZATIONS AND USE OF INFERIOR VENA CAVAL FILTERS IN OLDER ADULTS: NATIONAL STUDY OF MEDICARE BENEFICIARIES (2019) (1)
The Pleiotropic Effects of Statins : Fact or Fantasy ? (1)
AHA Scientific Statement Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension (2012) (1)
Chronic infection , Chlamydia and coronary heart disease – the story evolves (1)
Patients with perceived high-bleeding risk and computerized decision support for stroke prevention in atrial fibrillation: an AF-ALERT substudy (2020) (1)
Abstract 14043: A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis (2013) (1)
Further studies on the nature of the components in serum which inhibit mouse bone collagenase (2005) (1)
Abstract 20444: Betrixaban Reduces Not Only the Presence of Thrombus but Also Extent of Thrombus: An APEX Trial Substudy (2017) (1)
109Betrixaban compared to enoxaparin among obese acute medically ill subjects: an APEX trial subgroup analysis (2018) (1)
P3849Baseline profile of patients treated for acute venous thromboembolism in routine clinical practice according to age and renal function in the RE-COVERY DVT/PE global cohort study (2019) (1)
The Role of Antiplatelet Agents in Patients with Peripheral Vascular Disease (1995) (1)
Varraso et al. Respond to “Diet and Venous Thromboembolism” (2012) (1)
Thrombophilia (2013) (1)
Time to presentation for acute mi in the us physicians' health study (1990) (1)
P1623Association of low hemoglobin with venous thromboembolism in acutely ill hospitalized medical patients: findings from the APEX trial (2018) (1)
Safety, Efficacy of an Accelerated Regimen of Low-Dose Recombinant Tissue-Type Plasminogen Activator for Reperfusion Therapy of Acute Pulmonary Embolism (2021) (1)
Ximelagatran Versus Warfarin: A Comparison of Bleeding Outcomes in Patients with Nonvalvular Atrial Fibrillation. (2004) (1)
Patients with myeloproliferative neoplasms and COVID‐19 have increased rates of arterial thrombosis (2022) (1)
Pharmacomechanical Therapy for Deep-Vein Thrombosis. (2018) (1)
Pulmonary Embolism; 2nd ed., by Stein PD. (2008) (1)
Venous Thromboembolism G20210A Mutation in the Prothrombin Gene and the Risk of Recurrent Venous Thromboembolism (2016) (1)
Patent Foramen Ovale — Beauty Spot or Health Threat ? (1)
Response to Letter Regarding Article, “Effects of Random Allocation to Vitamin E Supplementation on the Occurrence of Venous Thromboembolism: Report From the Women’s Health Study” (2008) (0)
Impact of the Prediabetic State for the Treatment of Cardiovascular Disease in Prediabetic Patients (0)
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide (2022) (0)
Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis (2021) (0)
Is Lifelong Anticoagulation Worth the Risk in Patients With Unprovoked DVT (2009) (0)
Abstract 278: High Hospitalization Rates but Steady Improvement in Outcomes of US Older Adults with Pulmonary Embolism (2019) (0)
Stroke and Myocardial Infarction in Patients with Abdominal Aortic Aneurysm and New-Onset Atrial Fibrillation (2022) (0)
Do take that break. (2009) (0)
ONCE DAILY FONDAPARINUX MONOTHERAPY: A NEW OPTION FOR VENOUS THROMBOEMBOLISM PATIENTS INTOLERANT OF WARFARIN (2007) (0)
Anticoagulants and Transaminase Elevation C LINICIAN U PDATE C LINICIAN U PDATE (2006) (0)
Peripheral Vascular Disease - Fellows in Training Workshop 2015 Scientific Sessions Orange County Convention Center | Orlando, FL | Room W315AB (2015) (0)
Reasons for new patient warfarin referrals to an anticoagulant management service in 2019: a single institution experience (2020) (0)
Evaluation of the risk and prophylaxis of venous thrombo-embolic events in medical hospitalised patients: results in France of the international survey endorse (2009) (0)
Systemic or Venous Thromboembolism Global Anticoagulant Registry in the Field – Venous Thromboembolism ( GARFIELD-VTE ) Rationale and design (2016) (0)
P1892Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: a nationwide cohort study (2018) (0)
Long-Term Management of Venous Thromboembolism: Strategies for Reducing the Risk of Recurrence (2015) (0)
Diagnosis of Deep Vein Thrombosis: Incorporating Clinical Suspicion with Laboratory Testing and Imaging (2015) (0)
1099-89 The incidence of clinically unrecognized myocardial infarction in patients with type 2 diabetes, hypertension, and nephropathy (2004) (0)
Coronary artery revascularization and the risk of death in men with prostate cancer. (2011) (0)
Urologic Surgery (2013) (0)
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial. (2023) (0)
Medical Management of Venous Thromboembolic Disease (2000) (0)
Advanced Therapy for Venous Thromboembolism: Understanding the Role of Systemic Fibrinolysis, Catheter-Based Therapy, and Surgery (2015) (0)
Interruption of the Inferior Vena Cava by Clip or Filter (1984) (0)
Prevalence of factor V Leiden among women with pulmonary embolism or deep vein thrombosis during pregnancy or oral contraceptive use (1996) (0)
Doc, is my pulmonary embolism gone? (2008) (0)
Pharmacogenomics and Warfarin Anticoagulation (2009) (0)
Pulmonary Embolism Normal D-Dimer Levels in Emergency Department Patients Suspected of Acute Pulmonary Embolism (2016) (0)
chapter 54 – Pulmonary Embolism (2006) (0)
RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN SUBGROUPS OF MEN: A NATIONWIDE COHORT STUDY (2022) (0)
High-density lipoprotein metabolism as a therapeutic target for atherosclerosis (2003) (0)
Thromboembolism Management in Europe vs North America (2000) (0)
Ominous prognostic implications and inadequacy of heparin alone for right heart thrombi in patients with acute pulmonary embolism: analysis of baseline characteristics, echocardiograms, treatment, and clinical outcomes in the International Cooperative Pulmonary Embolism Registry (2002) (0)
Uninterrupted Oral Anticoagulation During Catheter Ablation of Ventricular Tachycardia: Is the Riskier Option the Safest? (2022) (0)
Deep Vein Thrombosis, Pulmonary Embolism, and Primary Pulmonary Hypertension (2003) (0)
Dosing of Tissue-Type Plasminogen Activator With the Acoustic Pulse Thrombolysis Procedure for Intermediate-Risk (Submassive) Pulmonary Embolism: ULTIMA, SEATTLE II, OPTALYSE PE (2017) (0)
Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in DVT Patients Receiving Pharmacomechanical Thrombolysis in a Multicenter Randomized Trial (2020) (0)
Abstract 14763: Patients With a Perceived High-bleeding Risk in a Randomized Controlled Trial of Alert-based Computerized Decision Support for Stroke Prevention in Atrial Fibrillation: An Af-Alert Substudy (2020) (0)
Development of an Institutional Periprocedural Management Guideline for Oral Anticoagulants. (2020) (0)
DEVELOPMENT OF A PREDICTION MODEL FOR RECURRENCE RISK AFTER INCIDENT VENOUS THROMBOEMBOLISM: A DANISH NATIONWIDE COHORT STUDY (2019) (0)
Tributes to Lewis Dexter. (2001) (0)
Risk Factors for Venous Thromboembolism: Recognizing the Spectrum of Risk and Understanding the Role of Thrombophilia Testing (2015) (0)
PRIOR HOSPITALIZATION WITHIN 30 DAYS PREDICTS INCREASED FREQUENCY OF DEATH, STROKE, AND BLEEDING IN ADVANCED ELDERLY OUTPATIENTS WITH ATRIAL FIBRILLATION (2017) (0)
ATRIAL FIBRILLATION TREATMENT PARADOX: CHARACTERISTICS OF AND FIRST-YEAR EVENTS IN PATIENTS NOT TREATED WITH VITAMIN-K ANTAGONISTS COMPARED TO TREATED PATIENTS. THE GARFIELD REGISTRY (2013) (0)
Practice Guidelines Chest Physicians Evidence-Based Clinical Thrombosis, 9th ed: American College of Antithrombotic Therapy and Prevention of Antithrombotic Therapy for VTE Disease : (2012) (0)
Diagnosis of Pulmonary Embolism: An Integrated Approach to Clinical Evaluation, Laboratory Testing, and Imaging (2015) (0)
USE OF ADVANCED THERAPIES FOR ACUTE PULMONARY EMBOLISM AND RELATED OUTCOMES AMONG FEE-FOR-SERVICE MEDICARE BENEFICIARIES FROM 1999 TO 2010 (2015) (0)
LOW EJECTION FRACTION: COMMON LINK BETWEEN ARTERIAL AND VENOUS EVENTS IN PATIENTS UNDERGOING PCI (2013) (0)
Dietary Treatment to prevent cardiovascular disease PART II : Effects on hyperlipidemia (0)
Monitoring anticoagulation. (2000) (0)
Sex-Related Differences in Patients Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study (2023) (0)
The guide to cardiology : pulmonary embolism (1992) (0)
Chronic Thromboembolic Pulmonary Hypertension: A Pathophysiologic Basis for Diagnosis and Management (2015) (0)
Dabigatran Etexilate or Warfarin in the Treatment of Acute Venous Thromboembolism in Western European Patients: A Pooled Analysis of RE-COVER ® and RE-COVER II™ (2015) (0)
TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE (1988) (0)
Clinical outcomes of patients with newly diagnosed atrial fibrillation who refused anticoagulation: findings from the global GARFIELD-AF registry (2020) (0)
Ask the doctor. I have been taking ginkgo pills for my memory for several years. I was just diagnosed with atrial fibrillation, and my doctor put me on Coumadin. Is it okay to keep taking ginkgo? (2010) (0)
Chapter 53 – Pulmonary Embolism (2013) (0)
Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion (2018) (0)
P4800Why do clinicians prescribe oral anticoagulation in patients with atrial fibrillation despite a low CHA2DS2-VASc score? (2018) (0)
P2895Evaluation of the effect of oral anticoagulants on all-cause mortality within 3 months of the diagnosis of atrial fibrillation: results from the GARFIELD-AF prospective registry (2018) (0)
How to use low-molecular-weight heparin to prevent DVT (2005) (0)
Prevention of pulmonary embolism: the nonpharmacological approach (1994) (0)
1123-186 International normalized ratio increase prior to warfarin-associated hemorrhage: Brief and subtle (2004) (0)
Deep Venous Thrombosis: Early Discharge Strategies and Outpatient Management (2004) (0)
Thromboembolic pulmonary disease (1990) (0)
Abstract 20326: Impact of Gender on Clinical Outcomes in Non-Valvular Atrial Fibrillation: Contemporary Perspective From the GARFIELD Registry (2014) (0)
1123-181 Thromboprophylaxis with dalteparin reduces clinically important venous thromboembolism in patients with congestive heart failure (2004) (0)
Chapter 38 – Pulmonary Embolism and Deep Vein Thrombosis (2013) (0)
Fourth Issue in Series (2004) (0)
Thrombolytic Therapy (1963) (0)
El tromboembolismo venoso y la enfermedad arterial coronaria comparten muchas similitudes Venous thromboembolism and coronary artery disease share many similarities (2012) (0)
Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial. (2022) (0)
Prevention of Postthrombotic Syndrome (2013) (0)
Coronary Flow Reserve, Inflammation, and Myocardial Strain (2022) (0)
Wednesday, 29 August 2012 (2012) (0)
Inferior Vena Cava Filters: Recognizing Indications for Placement and Retrieval (2015) (0)
National Investigators Collaborating on Enoxaparin (NICE-3) (2000) (0)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE COMPLICATED BY ACUTE DEEP VEIN THROMBOSIS: A HIGH-RISK COMBINATION (2007) (0)
CHARACTERIZATION OF 6,122 PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM IN ROUTINE CLINICAL PRACTICE: RE-COVERY DVT/PETM PROSPECTIVE GLOBAL COHORT STUDY (2018) (0)
inferior vena caval filters , high-volume experience with PE thrombolysis , catheter embolectomy , and surgical embolectomy (2008) (0)
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease (2022) (0)
Long term anticoagulation of idiopathic venous thromboembolism: do we have the answers? (2003) (0)
Thrombosis and Thromboembolism: New Strategies for Improved Patient Care (1998) (0)
Single photon emission computed tomography versus planar imaging in pulmonary perfusion defects (1986) (0)
Abstract 8712: Anticoagulation-Associated Adverse Drug Events (2011) (0)
1,375 HOSPITALIZED SURGICAL PATIENTS WITH ACUTE DVT: SYMPTOMS NOT CLASSIC AND PROPHYLAXIS RATES LOW (2007) (0)
Prevention of venous thromboembolism (2006) (0)
Belgian Society of Cardiology Belgian Heart Rhythm Association (BeHRA) (2011) (0)
Digital subtraction pulmonary angiography—An internist's and radiologist's view (2007) (0)
Contemporary Paradigms of Hypertrophic Cardiomyopathy (2005) (0)
P3848Baseline profile of patients treated for acute venous thromboembolism (VTE) in routine clinical practice according to VTE location in the RE-COVERY DVT/PE global cohort study (2019) (0)
Practice Guidelines for Noninvasive Positive-Pressure Ventilation (2015) (0)
FONDAPARINUX USE AT A MAJOR ACADEMIC MEDICAL CENTER (2008) (0)
A Scientific Statement From the American Heart Association Hypertension: Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Management of Massive and Submassive Pulmonary Embolism, Iliofemoral (2011) (0)
Venous thromboembolic risk and suboptimal prophylaxis in the US acute hospital care setting: Findings from the ENDORSE study (2007) (0)
Abbreviated hospitalization for DVT using a novel low molecular weight heparin, ardeparin: results of a randomized controlled trial (1998) (0)
REGIONAL RIGHT VENTRICULAR STRAIN PATTERN IN PATIENTS WITH PULMONARY EMBOLISM (2010) (0)
Is There a Role for Cardiac Troponin and Other Biomarkers in Patients With Pulmonary Embolism (2006) (0)
Venous thromboembolism: “…an ounce of prevention is worth a pound of cure” (2015) (0)
A-55 | Peripheral Pulmonary Blood Volume Decreases in Patients with Intermediate Risk Acute Pulmonary Embolism Treated with Anticoagulation (2022) (0)
Overview and Epidemiology of Venous Thromboembolism (2015) (0)
EFFICACY AND SAFETY OF DABIGATRAN ETEXILATE VERSUS VITAMIN K ANTAGONIST FOR TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM IN ROUTINE CLINICAL PRACTICE: RECOVERY DVT/PE PROSPECTIVE GLOBAL COHORT STUDY (2020) (0)
Post-thrombotic Syndrome: Recognizing and Treating a Debilitating Complication of Deep Vein Thrombosis (2015) (0)
A NEW METHOD TO QUANTIFY PERFUSION IMPAIRMENT DUE TO PULMONARY EMBOLISM ON A SIX VIEW GAMMA CAMERA SCINTIGRAPHY (1989) (0)
Ari Cedars Giovanni Filardo (2017) (0)
Coronary Flow Reserve, Inflammation and Myocardial Strain in the Cardiovascular Inflammation Reduction Trial (CIRT-CFR) (2022) (0)
Permanent discontinuation of different anticoagulants in patients with atrial fibrillation and the impact on clinical outcome: data from the GARFIELD-AF registry (2020) (0)
Abstract 14499: Impact of Pre-existing and New Incident Atrial Fibrillation on Outcomes of Patients With Acute Pulmonary Embolism: Findings From an International Registry (2020) (0)
DEEP VEIN THROMBOSIS IN ELDERLY PATIENTS: PROPHYLAXIS OFTEN OMITTED AND ATYPICAL PRESENTATION MORE FREQUENT (2007) (0)
P5599Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis (2017) (0)
Patient Management of Pulmonary Embolism (1988) (0)
Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF (2020) (0)
Profiles in Pulmonary Embolism (2000) (0)
Abstract 16347: Hypoalbuminemia and Its Association With Venous Thromboembolism in Acutely Ill Hospitalized Patients: Findings From the APEX Trial (2018) (0)
THROMBOEMBOLIC OUTCOMES IN HOSPITALIZED PATIENTS WITH UNDERLYING CARDIOVASCULAR DISEASE AND COVID-19 (2021) (0)
Thromboprophylaxis Strategies in Acute Medically Ill Patients (2019) (0)
Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry (2023) (0)
CARDIOVASCULAR EVENTS IN PATIENTS RECEIVING SULODEXIDE VERSUS CONTROL: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2019) (0)
General cardiology abstractNormal D-dimer levels in emergency department patients suspected of acute pulmonary embolism☆ (2003) (0)
Abstract 12001: Minimal Impact of Dabigatran on Patient Volume in Two Large Anticoagulation Management Services (2012) (0)
RECOMMENDED ARTICLE OF THE MONTH Comment on "Fibrinolysis for patients with intermediate-risk pulmonary embolism" (2015) (0)
Pathophysiology of Deep Vein Thrombosis and Pulmonary Embolism: Beyond Virchow’s Triad (2015) (0)
Impact of Atrial Fibrillation on In-Hospital Mortality and Stroke in Acute Aortic Syndromes. (2021) (0)
Case 34-2011: A Man with Memory Loss and Partial Seizures (2012) (0)
Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry (2021) (0)
Prevention of Venous Thromboembolism: An Evidence-Based Approach to Thromboprophylaxis (2015) (0)
Venous Thromboembolic DiseasePractice Guidelines in Oncology (2011) (0)
Giants in Chest Medicine: Jack Hirsh, CM, MD, DSc. (2017) (0)
CRT-300.15 Safety and Efficacy of Inferior Vena Cava Filters in Patients at Risk of Pulmonary Embolism: A Systematic Review and Meta-Analysis (2023) (0)
Venous thromboembolism prophylaxis – the need (2012) (0)
Restenosis : Is the cure finally here ? (0)
P6072Characterization of major and clinically relevant non-major bleeding in the APEX trial (2018) (0)
TEMPORAL TRENDS IN MANAGEMENT AND CLINICAL OUTCOMES OF PATIENTS WITH ACUTE PULMONARY EMBOLISM AFTER IMPLEMENTATION OF A MULTIDISCIPLINARY PULMONARY EMBOLISM RESPONSE TEAM (2022) (0)
EPIDEMIOLOGY OF THE LONG-TERM COMPLICATIONS FROM ACUTE VENOUS THROMBOEMBOLISM (2008) (0)
84 An innovative approach to clinical trial conduction using internet (1997) (0)
P3848Why do clinicians withhold anticoagulation in patients with atrial fibrillation and CHA2DS2VASc score of 2 or higher? (2018) (0)
Abstract 18040: Advanced Treatment of Submassive Pulmonary Embolism in 135 Patients Triaged by a Multidisciplinary Pulmonary Embolism Response Team (2016) (0)
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. (2022) (0)
Mortality related to pulmonary embolism in the United States before and during the COVID-19 pandemic: an analysis of the CDC Multiple Cause of Death database (2022) (0)
Comparing rivaroxaban and apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria (2021) (0)
Venous Thromboembolism (2020) (0)
Free-Floating Thrombus and Pulmonary Embolism-Reply (1997) (0)
Destaques do VII international symposium of thrombosis and anticoagulation (ISTA) (2015) (0)
State-of-the-Art Review : Prevention of Venous Thromboembolism in Major Orthopedic Surgery (1996) (0)
The use of single photon emission computed tomography in detecting pulmonary perfusion defects due to angiographically demonstrated emboli in man: assessment of accuracy and comparison with planar gamma camera (1987) (0)
Why do clinicians prescribe oral anticoagulation in patients with atrial fibrillation despite a low CHA2DS2-VASc score? (2019) (0)
The Controversy Surrounding Surgical Care Improvement Project-Venous Thromboembolism Process Measures (2017) (0)
P5600History of venous thromboembolism is associated with higher risk for recurrent venous thromboembolism: insights from the APEX trial (2017) (0)
Possible requiem: trial-and-error warfarin (2007) (0)
Hypercoagulable States and Other Risk Factors for Venous Thromboembolism (2016) (0)
Extended duration venous thromboembolism prophylaxis with betrixaban for patients re-admitted with venous thromboembolism (2021) (0)
PCV28 A COST ANALYSIS OF “BRIDGING THERAPY” FOR PATIENTS REQUIRING INTERRUPTION OF CHRONIC ANTICOAGULATION (2002) (0)
Outcomes at 1 year in atrial fibrillation patients with versus without an acute coronary syndrome: insights from the prospective GARFIELD Registry (2013) (0)
Corrigendum to “Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE” [Thromb. Res. 2020 Jul; 191:103–112] (2021) (0)
Effect of"fast track" admission foracute myocardial infarction ondelay tothrombolysis (1992) (0)
5998Echocardiographic improvement after short-duration, low-dose tPA regimens for ultrasound-facilitated, catheter-based fibrinolysis in submassive PE: OPTALYSE-PE (2017) (0)
Nursing Home Residents with Venous Thrombosis: A Vulnerable, Fragile and Disenfranchised Population (2018) (0)
Transient Ventricular Dysfunction Syndrome: The Evolving Nomenclature (2008) (0)
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study (2020) (0)
Revising the European Curriculum and Syllabus for IR (2017) (0)
COST ANALYSIS OF SUBSTITUTING DABIGATRAN FOR WARFARIN IN AN ANTICOAGULATION MANAGEMENT SERVICE (2011) (0)
Meningioma resection and venous thromboembolism incidence, management, and outcomes. (2023) (0)
Overview of Pulmonary Embolism (1999) (0)
Imaging. Improving healthcare delivery. (1998) (0)
PROPHYLAXIS USE INCREASES WITH ELECTRONIC ALERTS FOR PATIENTS AT HIGH VENOUS THROMBOEMBOLISM RISK (2006) (0)
Loss of Pulmonary Vascular Volume as a Predictor of Right Ventricular Dysfunction and Mortality in Acute Pulmonary Embolism (2021) (0)
Abstract 8642: A Randomized Controlled Trial of Physician Alerts to Prevent Symptomatic Venous Thromboembolism after Hospital Discharge (2011) (0)
Chapter 15 – Deep Vein Thrombosis and Pulmonary Embolism (2007) (0)
A NOVEL THREE-SCREEN COMPUTER ALERT TO INCREASE THE RATE OF VENOUS THROMBOEMBOLISM PROPHYLAXIS (2010) (0)
Thromboembolism management in Europe vs North America: are the differences clinically significant? (2000) (0)
Cardiovascular outcomes in hospitalized patients with COVID-19 and history of cancer: a CORONA-VTE analysis (2021) (0)
Abstract 9832: Individualized Patient Education Program for Prevention of Venous Thromboembolism in Hospitalized Medical Patients (2011) (0)
Rebuttal From Dr Goldhaber (2012) (0)
Deep Venous Thrombosis: A Comparison of Ethnic Groups From the DVT FREE Registr (2003) (0)
Prevalence of Coagulation Disorders in Patients With (2002) (0)
Dr Meyerovitz and colleagues respond (1991) (0)
Abstract 18182: Inferior Vena Caval Filter Use for Prevention of Pulmonary Embolism: A Systematic Review (2016) (0)
Contents (2020) (0)
Images in Vascular Medicine: Pulmonary embolism and acute aortic syndromes – Double trouble when vascular medicine emergencies meet (2021) (0)
cooperative pulmonary embolism registry Right heart thrombi in pulmonary embolism: Results from the international (2011) (0)
1123-182 Obesity does not attenuate the effectiveness of low-dose dalteparin in preventing venous thromboembolism in medically III patients (2004) (0)
Extended Apixaban Failed to Reduce VTE Risk in Medically Ill Patients (2011) (0)
Ask the doctor. Is warfarin turning my toes purple? (2007) (0)
Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study (2022) (0)
Safety and efficacy of apixaban and rivaroxaban versus warfarin in real-world atrial fibrillation patients are similar to their randomized trials: insights from GARFIELD-AF registry (2021) (0)
Thromboprophylaxis With Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Respiratory Failur (2003) (0)
P1551D-dimer concentration is associated with increased risk for VTE and greater absolute benefit of extended prophylaxis with betrixaban in acutely Ill medical patients: insights from the APEX trial (2017) (0)
Anticoagulation for Venous Thromboembolism: Selecting the Optimal Parenteral and Oral Anticoagulant Regimen (2015) (0)
Risk Stratification and Prognosis: Identifying Patients Who May Benefit from Advanced Therapies (2015) (0)
Venous thromboembolic disease. (2013) (0)
Pattern of Liver Function Test Abnormalities and the Usual Course (2006) (0)
External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial (2022) (0)
Other looks at SRR (1995) (0)
Balancing Competing Risks of Recurrence and Death from High-risk Prostate Cancer Versus Cardiovascular Mortality in Men Treated With Hormonal Therapy: A Decision Analysis (2012) (0)
PHARMACOLOGIC PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM: THE MOST FREQUENT REASON FOR OMITTING ORDERED DOSES IS PATIENT REFUSAL (2010) (0)
Contractile failure during ischemia and congestive heart failure : role of defective excitation-contraction coupling (0)
Temporal trends in medical cardioprotective treatment in patients with abdominal aortic aneurysms: A population-based national cohort study (2022) (0)
Optimal Intensity of Anticoagulation: A Narrow Therapeutic Range (2002) (0)
Abstract 19208: Extended Duration Betrixaban Reduces the Risk of Stroke vs Standard Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Substudy (2016) (0)
Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19 (2021) (0)
Abstract 549: Impact Of ST Segment Elevation On In-hospital Mortality And Stroke In Acute Aortic Syndromes (2022) (0)
PRECEDENT AND INCIDENT ATRIAL FIBRILLATION ARE ASSOCIATED WITH INCREASED MORTALITY IN PULMONARY EMBOLISM: FINDINGS FROM A MULTINATIONAL COHORT STUDY (2020) (0)
P4601Differences in two-year outcomes according to type of atrial fibrillation: results from the GARFIELD-AF registry (2017) (0)
Acute Pulmonary Embolism (2002) (0)
EARLY MORTALITY IN PATIENTS WITH NEW ONSET ATRIAL FIBRILLATION: RESULTS FROM THE GARFIELD-AF REGISTRY (2017) (0)
Abstract 13924: Covid-19 Registry to Assess Frequency, Management, and Outcomes of Arterial and Venous Thromboembolic Complications (CORONA-VTE) (2020) (0)
Abstract 18977: Trends in Use of Thrombolytic Therapy Among Fee-For-Service Medicare Beneficiaries With Acute Pulmonary Embolism (2013) (0)
PULMONARY EMBOLISM IN HOSPITAL PRACTICE : LESSONS FROM THE INTERNATIONAL COOPERATIVE PULMONARY EMBOLISM REGISTRY (ICOPER) (1997) (0)
Venous Thromboembolism d-Dimer and the Intensive Care Unit (2000) (0)
Changes in antithrombotic treatment in patients with abdominal aortic aneurysmal disease and incident atrial fibrillation: a population-based case-crossover analyses (2021) (0)
858-3 Subcutaneous treprostinil therapy evokes both survival benefit and continuous dose-dependent efficacy improvements in patients with pulmonary arterial hypertension: A long-term European multicentre analysis of 112 patients (2016) (0)
Book Review: Thrombolytic Therapy (2000) (0)
Angioplasty or coronary bypass graft? (1993) (0)
Tissue Plasminogen Activator in Cardiopulmonary Disease (1989) (0)
P4316N-terminal pro-B-type natriuretic peptide (NT-proBNP) is associated with stroke among hospitalized medical patients: an APEX trial substudy (2017) (0)
Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF (2022) (0)
EPIDEMIOLOGY OF VENOUS THROMBOEMBOLISM IN ACUTELY ILL MEDICAL PATIENTS IN THE USA (2008) (0)
Guideline adherence and clinical outcomes of patients with acute pulmonary embolism evaluated by a multidisciplinary response team at a quaternary care center. (2022) (0)
Corrigendum to “Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE” [Thromb. Res. 2021 May;201:63–72] (2022) (0)
Abstract 16125: Prognostic Value of C-Reactive Protein as Inflammatory Marker for Venous Thromboembolism in Acutely Ill Hospitalized Patients: Analysis From the APEX Trial (2018) (0)
Increased relative weight — A risk factor for major pulmonary embolism: The Framingham study (1982) (0)
TwoTrials ofReducedBolusAlteplase in theTreatment ofPulmonary Embolism (2015) (0)
Catheter-Directed Intervention for Acute Pulmonary Embolism: Response (2008) (0)
Pharmacogentic factors affecting INR control during warfarin initiation (2008) (0)
Regulatory, legislative, and policy updates with anticoagulant use (2015) (0)
Abstract No. 602 Rationale and experimental design of the KNOCOUT PE trial: an international EKoSoNic® registry of the treatment and clinical outcomes of patients with pulmonary embolism (2019) (0)
P1732Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Samuel Zachary Goldhaber?

Samuel Zachary Goldhaber is affiliated with the following schools: